TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs116988415
log Bayes Factor = 1.2421
Chromosome 14   position 65,292,145  (GRCh37) Explore rs116988415 on Ensembl!
Variant rs116988415 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
Z50 Care involving use of rehabilitation procedures
0.000 0.162 0.838
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified
0.000 0.166 0.834
Z50.1 Other physical therapy
0.000 0.183 0.817
Z50.5 Speech therapy
0.000 0.203 0.797
Z50.9 Care involving use of rehabilitation procedure, unspecified
0.000 0.260 0.740
Z50.2 Alcohol rehabilitation
0.000 0.275 0.725
Z50.4 Psychotherapy, not elsewhere classified
0.000 0.277 0.722
Z50.8 Care involving use of rehabilitation procedures
0.000 0.320 0.680
Z50.6 Orthoptic training
0.000 0.399 0.601
Z50.3 Drug rehabilitation
0.000 0.399 0.601
Z50.0 Cardiac rehabilitation
0.000 0.434 0.566
H65-H75 Diseases of middle ear and mastoid
0.000 0.586 0.414
H66 Suppurative and unspecified otitis media
0.000 0.587 0.413
H65 Nonsuppurative otitis media
0.000 0.589 0.411
H66.3 Other chronic suppurative otitis media
0.000 0.597 0.403
H73 Other disorders of tympanic membrane
0.000 0.606 0.394
H65.3 Chronic mucoid otitis media
0.000 0.609 0.391
H65.9 Nonsuppurative otitis media, unspecified
0.000 0.616 0.384
H66.9 Otitis media, unspecified
0.000 0.618 0.382
H73.8 Other specified disorders of tympanic membrane
0.000 0.620 0.380
Chapter VIII Diseases of the ear and mastoid process
0.000 0.670 0.330
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.678 0.322
H60-H62 Diseases of external ear
0.000 0.684 0.316
H65.4 Other chronic nonsuppurative otitis media
0.000 0.685 0.315
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.686 0.314
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.688 0.312
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.691 0.309
C85.1 B-cell lymphoma, unspecified
0.000 0.691 0.309
H61 Other disorders of external ear
0.000 0.692 0.308
H61.2 Impacted cerumen
0.000 0.697 0.303
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere
0.000 0.703 0.297
H68 Eustachian salpingitis and obstruction
0.000 0.703 0.297
H67 Otitis media in diseases classified elsewhere
0.000 0.703 0.297
H66.4 Suppurative otitis media, unspecified
0.000 0.704 0.296
H66.2 Chronic atticoantral suppurative otitis media
0.000 0.704 0.296
H66.1 Chronic tubotympanic suppurative otitis media
0.000 0.704 0.296
H66.0 Acute suppurative otitis media
0.000 0.704 0.296
H71 Cholesteatoma of middle ear
0.000 0.704 0.296
C83.3 Large cell (diffuse)
0.000 0.704 0.296
C83.0 Small cell (diffuse)
0.000 0.705 0.295
H65.1 Other acute nonsuppurative otitis media
0.000 0.705 0.294
H65.0 Acute serous otitis media
0.000 0.705 0.294
H65.2 Chronic serous otitis media
0.000 0.709 0.291
H70 Mastoiditis and related conditions
0.000 0.713 0.287
H73.9 Disorder of tympanic membrane, unspecified
0.000 0.717 0.282
H73.1 Chronic myringitis
0.000 0.717 0.282
H73.0 Acute myringitis
0.000 0.717 0.282
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.720 0.280
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.730 0.270
H69 Other disorders of Eustachian tube
0.000 0.734 0.266
C90 Multiple myeloma and malignant plasma cell neoplasms
0.000 0.744 0.256
C91 Lymphoid leukaemia
0.000 0.745 0.254
C81 Hodgkin's disease
0.000 0.747 0.252
H74 Other disorders of middle ear and mastoid
0.000 0.751 0.249
H90-H95 Other disorders of ear
0.000 0.758 0.242
H61.3 Acquired stenosis of external ear canal
0.000 0.767 0.233
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.767 0.232
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.768 0.232
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.769 0.231
C85.0 Lymphosarcoma
0.000 0.769 0.231
H62 Disorders of external ear in diseases classified elsewhere
0.000 0.773 0.227
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.774 0.225
C94 Other leukaemias of specified cell type
0.000 0.774 0.225
C93 Monocytic leukaemia
0.000 0.774 0.225
C86 Other specified types of T/NK-cell lymphoma
0.000 0.774 0.225
H72 Perforation of tympanic membrane
0.000 0.775 0.225
C83.7 Burkitt's tumour
0.000 0.776 0.223
C83.6 Undifferentiated (diffuse)
0.000 0.776 0.223
C83.5 Lymphoblastic (diffuse)
0.000 0.776 0.223
C83.4 Immunoblastic (diffuse)
0.000 0.776 0.223
C83.2 Mixed small and large cell (diffuse)
0.000 0.776 0.223
C83.1 Small cleaved cell (diffuse)
0.000 0.776 0.223
H61.8 Other specified disorders of external ear
0.000 0.777 0.223
H61.0 Perichondritis of external ear
0.000 0.778 0.222
H61.9 Disorder of external ear, unspecified
0.000 0.779 0.221
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.779 0.220
H74.8 Other specified disorders of middle ear and mastoid
0.000 0.785 0.215
C95 Leukaemia of unspecified cell type
0.000 0.786 0.214
C90.0 Multiple myeloma
0.000 0.786 0.214
H80-H83 Diseases of inner ear
0.000 0.786 0.214
H67.8 Otitis media in other diseases classified elsewhere
0.000 0.787 0.213
H67.1 Otitis media in viral diseases classified elsewhere
0.000 0.787 0.213
H67.0 Otitis media in bacterial diseases classified elsewhere
0.000 0.787 0.213
H68.1 Obstruction of Eustachian tube
0.000 0.787 0.213
H68.0 Eustachian salpingitis
0.000 0.787 0.213
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere
0.000 0.787 0.213
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere
0.000 0.787 0.213
H61.1 Non-infective disorders of pinna
0.000 0.787 0.213
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.000 0.787 0.213
H60 Otitis externa
0.000 0.787 0.212
C91.1 Chronic lymphocytic leukaemia
0.000 0.789 0.211
H70.8 Other mastoiditis and related conditions
0.000 0.794 0.206
H70.2 Petrositis
0.000 0.794 0.206
H70.1 Chronic mastoiditis
0.000 0.794 0.206
H70.0 Acute mastoiditis
0.000 0.794 0.206
C82.1 Mixed small cleaved and large cell, follicular
0.000 0.795 0.205
C81.9 Hodgkin's disease, unspecified
0.000 0.795 0.205
H90 Conductive and sensorineural hearing loss
0.000 0.799 0.201
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.803 0.197
H74.0 Tympanosclerosis
0.000 0.804 0.196
H70.9 Mastoiditis, unspecified
0.000 0.804 0.195
C82.6 Cutaneous follicle centre lymphoma
0.000 0.806 0.194
C82.5 Diffuse follicle centre lymphoma
0.000 0.806 0.194
C82.4 Follicular lymphoma grade IIIb
0.000 0.806 0.194
C82.3 Follicular lymphoma grade IIIa
0.000 0.806 0.194
C82.2 Large cell, follicular
0.000 0.806 0.194
C82.0 Small cleaved cell, follicular
0.000 0.807 0.193
H69.8 Other specified disorders of Eustachian tube
0.000 0.809 0.191
H69.0 Patulous Eustachian tube
0.000 0.809 0.191
C92 Myeloid leukaemia
0.000 0.809 0.191
C81.1 Nodular sclerosis
0.000 0.814 0.186
C91.0 Acute lymphoblastic leukaemia
0.000 0.814 0.186
H72.0 Central perforation of tympanic membrane
0.000 0.815 0.185
C90.3 Solitary plasmacytoma
0.000 0.816 0.184
C90.2 Plasmacytoma, extramedullary
0.000 0.816 0.184
C90.1 Plasma cell leukaemia
0.000 0.816 0.184
H93 Other disorders of ear, not elsewhere classified
0.000 0.816 0.184
C91.9 Lymphoid leukaemia, unspecified
0.000 0.817 0.183
C91.8 Mature B-cell leukaemia Burkitt-type
0.000 0.817 0.183
C91.7 Other lymphoid leukaemia
0.000 0.817 0.183
C91.6 Prolymphocytic leukaemia of T-cell type
0.000 0.817 0.183
C91.5 Adult T-cell leukaemia
0.000 0.817 0.183
C91.3 Prolymphocytic leukaemia
0.000 0.817 0.183
C91.2 Subacute lymphocytic leukaemia
0.000 0.817 0.183
H92 Otalgia and effusion of ear
0.000 0.819 0.181
C81.7 Other Hodgkin's disease
0.000 0.819 0.181
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.000 0.819 0.181
C81.3 Lymphocytic depletion
0.000 0.819 0.181
C81.2 Mixed cellularity
0.000 0.819 0.181
C81.0 Lymphocytic predominance
0.000 0.819 0.181
C91.4 Hairy-cell leukaemia
0.000 0.820 0.180
H74.2 Discontinuity and dislocation of ear ossicles
0.000 0.821 0.179
C84.5 Other and unspecified T-cell lymphomas
0.000 0.823 0.177
H81 Disorders of vestibular function
0.000 0.823 0.177
H90.5 Sensorineural hearing loss, unspecified
0.000 0.826 0.174
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified
0.000 0.826 0.173
H94 Other disorders of ear in diseases classified elsewhere
0.000 0.826 0.173
C88 Malignant immunoproliferative diseases
0.001 0.828 0.172
H60.9 Otitis externa, unspecified
0.000 0.830 0.170
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.833 0.166
C84.8 Cutaneous T-cell lymphoma, unspecified
0.000 0.833 0.166
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.833 0.166
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.833 0.166
C84.3 Lymphoepithelioid lymphoma
0.000 0.833 0.166
C84.2 T-zone lymphoma
0.000 0.833 0.166
C84.1 Sezary's diease
0.000 0.833 0.166
C84.0 Mycosis fungoides
0.000 0.833 0.166
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.836 0.164
H62.8 Other disorders of external ear in diseases classified elsewhere
0.000 0.837 0.163
H62.4 Otitis externa in other diseases classified elsewhere
0.000 0.837 0.163
H62.3 Otitis externa in other infectious and parasitic diseases classified elsewhere
0.000 0.837 0.163
H62.2 Otitis externa in mycoses
0.000 0.837 0.163
H62.1 Otitis externa in viral diseases classified elsewhere
0.000 0.837 0.163
H62.0 Otitis externa in bacterial diseases classified elsewhere
0.000 0.837 0.163
C84.4 Peripheral T-cell lymphoma
0.000 0.838 0.162
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.838 0.162
C86.5 Angioimmunoblastic T-cell lymphoma
0.000 0.838 0.162
C86.4 Blastic NK-cell lymphoma
0.000 0.838 0.162
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.838 0.162
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.838 0.162
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.838 0.162
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.838 0.162
C93.9 Monocytic leukaemia, unspecified
0.000 0.838 0.162
C93.7 Other monocytic leukaemia
0.000 0.838 0.162
C93.3 Juvenile myelomonocytic leukaemia
0.000 0.838 0.162
C93.2 Subacute monocytic leukaemia
0.000 0.838 0.162
C93.1 Chronic monocytic leukaemia
0.000 0.838 0.162
C93.0 Acute monocytic leukaemia
0.000 0.838 0.162
C94.7 Other specified leukaemias
0.000 0.838 0.162
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.000 0.838 0.162
C94.5 Acute myelofibrosis
0.000 0.838 0.162
C94.4 Acute panmyelosis
0.000 0.838 0.162
C94.3 Mast cell leukaemia
0.000 0.838 0.162
C94.2 Acute megakaryoblastic leukaemia
0.000 0.838 0.162
C94.1 Chronic erythraemia
0.000 0.838 0.162
C94.0 Acute erythraemia and erythroleukaemia
0.000 0.838 0.162
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.838 0.162
C96.8 Histiocytic sarcoma
0.000 0.838 0.162
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.838 0.162
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.838 0.162
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.838 0.162
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.838 0.162
C96.3 True histiocytic lymphoma
0.000 0.838 0.162
C96.2 Malignant mast cell tumour
0.000 0.838 0.162
C96.1 Malignant histiocytosis
0.000 0.838 0.162
C96.0 Letterer-Siwe disease
0.000 0.838 0.162
H72.2 Other marginal perforations of tympanic membrane
0.000 0.838 0.161
H72.8 Other perforations of tympanic membrane
0.000 0.839 0.160
H90.0 Conductive hearing loss, bilateral
0.000 0.839 0.160
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.840 0.159
H69.9 Eustachian tube disorder, unspecified
0.000 0.841 0.159
H60.3 Other infective otitis externa
0.000 0.841 0.159
H74.1 Adhesive middle ear disease
0.000 0.843 0.156
H74.4 Polyp of middle ear
0.000 0.846 0.154
C95.7 Other leukaemia of unspecified cell type
0.000 0.846 0.154
C95.2 Subacute leukaemia of unspecified cell type
0.000 0.846 0.154
C95.1 Chronic leukaemia of unspecified cell type
0.000 0.846 0.154
C95.0 Acute leukaemia of unspecified cell type
0.000 0.846 0.154
H82 Vertiginous syndromes in diseases classified elsewhere
0.000 0.847 0.153
H92.1 Otorrhoea
0.000 0.847 0.153
H60.8 Other otitis externa
0.000 0.847 0.152
H60.5 Acute otitis externa, non-infective
0.000 0.847 0.152
H60.4 Cholesteatoma of external ear
0.000 0.847 0.152
H60.2 Malignant otitis externa
0.000 0.847 0.152
H60.0 Abscess of external ear
0.000 0.847 0.152
H93.1 Tinnitus
0.000 0.848 0.152
H74.3 Other acquired abnormalities of ear ossicles
0.000 0.849 0.151
H81.0 Meniere's disease
0.000 0.852 0.148
H81.2 Vestibular neuronitis
0.000 0.854 0.146
H90.8 Mixed conductive and sensorineural hearing loss, unspecified
0.000 0.856 0.144
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.856 0.144
C95.9 Leukaemia, unspecified
0.000 0.857 0.142
H72.1 Attic perforation of tympanic membrane
0.000 0.863 0.137
C92.9 Myeloid leukaemia, unspecified
0.000 0.863 0.137
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.000 0.863 0.137
C92.7 Other myeloid leukaemia
0.000 0.863 0.137
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.000 0.863 0.137
C92.5 Acute myelomonocytic leukaemia
0.000 0.863 0.137
C92.4 Acute promyelocytic leukaemia
0.000 0.863 0.137
C92.3 Myeloid sarcoma
0.000 0.863 0.137
C92.2 Subacute myeloid leukaemia
0.000 0.863 0.137
C92.0 Acute myeloid leukaemia
0.000 0.863 0.136
H93.3 Disorders of acoustic nerve
0.000 0.868 0.132
H93.2 Other abnormal auditory perceptions
0.000 0.868 0.132
H93.0 Degenerative and vascular disorders of ear
0.000 0.868 0.132
H90.6 Mixed conductive and sensorineural hearing loss, bilateral
0.000 0.868 0.132
H90.3 Sensorineural hearing loss, bilateral
0.000 0.868 0.132
H93.8 Other specified disorders of ear
0.000 0.869 0.131
H92.2 Otorrhagia
0.000 0.870 0.130
H80 Otosclerosis
0.000 0.872 0.128
H81.9 Disorder of vestibular function, unspecified
0.000 0.873 0.127
H81.8 Other disorders of vestibular function
0.000 0.873 0.127
H81.4 Vertigo of central origin
0.000 0.873 0.127
H81.3 Other peripheral vertigo
0.000 0.873 0.127
H94.8 Other specified disorders of ear in diseases classified elsewhere
0.000 0.875 0.124
H94.0 Acoustic neuritis in infectious and parasitic diseases classified elsewhere
0.000 0.875 0.124
H95.9 Postprocedural disorder of ear and mastoid process, unspecified
0.000 0.875 0.124
H95.8 Other postprocedural disorders of ear and mastoid process
0.000 0.875 0.124
H95.1 Other disorders following mastoidectomy
0.000 0.875 0.124
H95.0 Recurrent cholesteatoma of postmastoidectomy cavity
0.000 0.875 0.124
C88.9 Malignant immunoproliferative disease, unspecified
0.001 0.876 0.123
C88.7 Other malignant immunoproliferative diseases
0.001 0.876 0.123
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.001 0.876 0.123
C88.3 Immunoproliferative small intestinal disease
0.001 0.876 0.123
C88.2 Gamma heavy chain disease
0.001 0.876 0.123
C88.1 Alpha heavy chain disease
0.001 0.876 0.123
H83 Other diseases of inner ear
0.000 0.882 0.118
H74.9 Disorder of middle ear and mastoid, unspecified
0.001 0.882 0.117
H93.9 Disorder of ear, unspecified
0.000 0.883 0.117
C92.1 Chronic myeloid leukaemia
0.000 0.897 0.103
H92.0 Otalgia
0.000 0.897 0.103
H91 Other hearing loss
0.000 0.898 0.102
H81.1 Benign paroxysmal vertigo
0.000 0.899 0.101
H60.1 Cellulitis of external ear
0.001 0.904 0.095
H80.8 Other otosclerosis
0.000 0.908 0.092
H80.2 Cochlear otosclerosis
0.000 0.908 0.092
H80.1 Otosclerosis involving oval window, obliterative
0.000 0.908 0.092
H80.0 Otosclerosis involving oval window, nonobliterative
0.000 0.908 0.092
H83.9 Disease of inner ear, unspecified
0.000 0.915 0.085
H83.8 Other specified diseases of inner ear
0.000 0.915 0.085
H83.3 Noise effects on inner ear
0.000 0.915 0.085
H83.2 Labyrinthine dysfunction
0.000 0.915 0.085
H83.1 Labyrinthine fistula
0.000 0.915 0.085
H90.2 Conductive hearing loss, unspecified
0.000 0.917 0.082
H91.2 Sudden idiopathic hearing loss
0.000 0.926 0.073
H91.0 Ototoxic hearing loss
0.000 0.926 0.073
H72.9 Perforation of tympanic membrane, unspecified
0.000 0.929 0.071
C88.0 Waldenstrom's macroglobulinaemia
0.001 0.929 0.070
H91.1 Presbycusis
0.000 0.931 0.068
H91.3 Deaf mutism, not elsewhere classified
0.000 0.932 0.068
H80.9 Otosclerosis, unspecified
0.000 0.933 0.067
H91.8 Other specified hearing loss
0.000 0.935 0.065
I95.1 Orthostatic hypotension
0.000 0.945 0.055
H83.0 Labyrinthitis
0.000 0.950 0.049
H91.9 Hearing loss, unspecified
0.000 0.954 0.046
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
0.000 0.979 0.021
R29 Other symptoms and signs involving the nervous and musculoskeletal systems
0.000 0.979 0.021
Z47.0 Follow-up care involving removal of fracture plate and other internal fixation device
0.000 0.979 0.021
R29.6 Tendency to fall, not elsewhere classified
0.000 0.979 0.021
M20.4 Other hammer toe(s) (acquired)
0.018 0.982 0.000
R25-R29 Symptoms and signs involving the nervous and musculoskeletal systems
0.000 0.982 0.018
R26 Abnormalities of gait and mobility
0.000 0.983 0.017
R26.8 Other and unspecified abnormalities of gait and mobility
0.000 0.983 0.017
M54.99 Dorsalgia, unspecified (Site unspecified)
0.016 0.984 0.000
R29.4 Clicking hip
0.000 0.984 0.015
R29.3 Abnormal posture
0.000 0.984 0.015
R29.2 Abnormal reflex
0.000 0.984 0.015
R29.1 Meningismus
0.000 0.984 0.015
R29.0 Tetany
0.000 0.984 0.015
K80.5 Calculus of bile duct without cholangitis or cholecystitis
0.015 0.985 0.000
Z47 Other orthopaedic follow-up care
0.000 0.985 0.015
R25 Abnormal involuntary movements
0.000 0.985 0.015
W19.2 School, other institution and public administrative area
0.000 0.985 0.015
W19 Unspecified fall
0.000 0.986 0.014
W19.9 Unspecified place
0.000 0.987 0.013
Z40-Z54 Persons encountering health services for specific procedures and health care
0.000 0.987 0.013
R25.2 Cramp and spasm
0.000 0.987 0.013
R26.2 Difficulty in walking, not elsewhere classified
0.000 0.987 0.013
G81.9 Hemiplegia, unspecified
0.000 0.987 0.013
R26.3 Immobility
0.000 0.987 0.013
R27 Other lack of coordination
0.000 0.987 0.013
R26.1 Paralytic gait
0.000 0.987 0.012
M54.9 Dorsalgia, unspecified
0.012 0.988 0.000
W19.4 Street and highway
0.000 0.988 0.012
I95 Hypotension
0.000 0.989 0.011
R25.8 Other and unspecified abnormal involuntary movements
0.000 0.989 0.011
R26.0 Ataxic gait
0.000 0.989 0.011
M54.92 Dorsalgia, unspecified (Cervical region)
0.011 0.989 0.000
Z47.9 Orthopaedic follow-up care, unspecified
0.000 0.989 0.011
R25.1 Tremor, unspecified
0.000 0.989 0.011
W19.1 Residential institution
0.000 0.989 0.011
S61.8 Open wound of other parts of wrist and hand
0.011 0.989 0.000
R25.0 Abnormal head movements
0.000 0.989 0.011
M54.97 Dorsalgia, unspecified (Lumbosacral region)
0.011 0.989 0.000
N28.8 Other specified disorders of kidney and ureter
0.011 0.989 0.000
R27.0 Ataxia, unspecified
0.000 0.990 0.010
N92.1 Excessive and frequent menstruation with irregular cycle
0.010 0.990 0.000
Z43 Attention to artificial openings
0.000 0.990 0.010
W19.8 Other specified place
0.000 0.990 0.010
W19.5 Trade and service area
0.000 0.990 0.010
W19.0 Home
0.000 0.990 0.010
W19.7 Farm
0.000 0.990 0.010
W19.6 Industrial and construction area
0.000 0.990 0.010
C15.9 Oesophagus, unspecified
0.010 0.990 0.000
Z45 Adjustment and management of implanted device
0.000 0.990 0.010
M54.94 Dorsalgia, unspecified (Thoracic region)
0.010 0.990 0.000
Z54 Convalescence
0.000 0.990 0.010
R25.3 Fasciculation
0.000 0.990 0.009
M54.96 Dorsalgia, unspecified (Lumbar region)
0.010 0.990 0.000
W19.3 Sports and athletics area
0.000 0.991 0.009
Z08.7 Follow-up examination after combined treatment for malignant neoplasm
0.009 0.991 0.000
Z43.6 Attention to other artificial openings of urinary tract
0.000 0.991 0.009
Z43.4 Attention to other artificial openings of digestive tract
0.000 0.991 0.009
M54.95 Dorsalgia, unspecified (Thoracolumbar region)
0.009 0.991 0.000
M54.93 Dorsalgia, unspecified (Cervicothoracic region)
0.009 0.991 0.000
M54.91 Dorsalgia, unspecified (Occipito-atlanto-axial region)
0.009 0.991 0.000
Z45.2 Adjustment and management of vascular access device
0.000 0.991 0.009
I95.8 Other hypotension
0.000 0.991 0.009
M54.90 Dorsalgia, unspecified (Multiple sites in spine)
0.009 0.991 0.000
Z49 Care involving dialysis
0.000 0.991 0.009
Z44 Fitting and adjustment of external prosthetic device
0.000 0.991 0.009
M54.98 Dorsalgia, unspecified (Sacral and sacrococcygeal region)
0.008 0.991 0.000
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)
0.000 0.991 0.008
R27.8 Other and unspecified lack of coordination
0.000 0.991 0.008
C15 Malignant neoplasm of oesophagus
0.008 0.992 0.000
S06.5 Traumatic subdural haemorrhage
0.000 0.992 0.008
Z43.2 Attention to ileostomy
0.000 0.992 0.008
Z45.8 Adjustment and management of other implanted devices
0.000 0.992 0.008
S06 Intracranial injury
0.000 0.992 0.008
M20 Acquired deformities of fingers and toes
0.008 0.992 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.008 0.992 0.000
S06.20 Diffuse brain injury (without open intracranial wound)
0.000 0.992 0.008
Z52 Donors of organs and tissues
0.000 0.992 0.008
S06.2 Diffuse brain injury
0.000 0.992 0.008
Z41 Procedures for purposes other than remedying health state
0.000 0.992 0.008
C15.5 Lower third of oesophagus
0.008 0.992 0.000
Z43.9 Attention to unspecified artificial opening
0.000 0.992 0.008
Z43.7 Attention to artificial vagina
0.000 0.992 0.008
Z88.2 Personal history of allergy to sulphonamides
0.008 0.992 0.000
Z43.5 Attention to cyctostomy
0.000 0.992 0.008
W19.09 Unspecified fall; Home; During unspecified activity
0.000 0.992 0.007
W19.08 Unspecified fall; Home; While engaged in other specified activities
0.000 0.992 0.007
W19.59 Unspecified fall; Trade and service area; During unspecified activity
0.000 0.992 0.007
W19.81 Unspecified fall; Other specified places; While engaged in leisure activity
0.000 0.992 0.007
Z54.0 Convalescence following surgery
0.000 0.993 0.007
Z45.9 Adjustment and management of unspecified implanted device
0.000 0.993 0.007
Z45.3 Adjustment and management of implanted hearing device
0.000 0.993 0.007
S06.6 Traumatic subarachnoid haemorrhage
0.000 0.993 0.007
Z54.9 Convalescence following unspecified treatment
0.000 0.993 0.007
Z54.8 Convalescence following other treatment
0.000 0.993 0.007
Z54.7 Convalescence following combined treatment
0.000 0.993 0.007
Z54.4 Convalescence following treatment of fracture
0.000 0.993 0.007
Z54.3 Convalescence following psychotherapy
0.000 0.993 0.007
Z54.2 Convalescence following chemotherapy
0.000 0.993 0.007
Z54.1 Convalescence following radiotherapy
0.000 0.993 0.007
Z43.3 Attention to colostomy
0.000 0.993 0.007
M20.3 Other deformity of hallux (acquired)
0.007 0.993 0.000
C15.3 Upper third of oesophagus
0.007 0.993 0.000
M20.5 Other deformities of toe(s) (acquired)
0.007 0.993 0.000
M20.0 Deformity of finger(s)
0.007 0.993 0.000
Z43.8 Attention to other artificial openings
0.000 0.993 0.007
Z47.8 Other specified orthopaedic follow-up care
0.000 0.993 0.007
Z43.0 Attention to tracheostomy
0.000 0.993 0.007
Z49.1 Extracorporeal dialysis
0.000 0.993 0.007
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)
0.000 0.993 0.007
Z42 Follow-up care involving plastic surgery
0.000 0.993 0.007
S06.8 Other intracranial injuries
0.000 0.993 0.007
S06.4 Epidural haemorrhage
0.000 0.993 0.007
Z45.1 Adjustment and management of infusion pump
0.000 0.993 0.007
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.007 0.993 0.000
I95.0 Idiopathic hypotension
0.000 0.993 0.006
Z46 Fitting and adjustment of other devices
0.000 0.993 0.007
Z44.9 Fitting and adjustment of unspecified external prosthetic device
0.000 0.993 0.006
Z44.8 Fitting and adjustment of other external prosthetic devices
0.000 0.993 0.006
Z44.2 Fitting and adjustment of artificial eye
0.000 0.993 0.006
Z44.1 Fitting and adjustment of artificial leg (complete)(partial)
0.000 0.993 0.006
Z44.0 Fitting and adjustment of artificial arm (complete)(partial)
0.000 0.993 0.006
S06.3 Focal brain injury
0.000 0.994 0.006
I95.2 Hypotension due to drugs
0.000 0.994 0.006
C15.8 Overlapping lesion of oesophagus
0.006 0.994 0.000
C15.2 Abdominal part of oesophagus
0.006 0.994 0.000
C15.1 Thoracic part of oesophagus
0.006 0.994 0.000
C15.0 Cervical part of oesophagus
0.006 0.994 0.000
Z49.2 Other dialysis
0.000 0.994 0.006
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)
0.000 0.994 0.006
S06.7 Intracranial injury with prolonged coma
0.000 0.994 0.006
S06.1 Traumatic cerebral oedema
0.000 0.994 0.006
C15.4 Middle third of oesophagus
0.006 0.994 0.000
S06.9 Intracranial injury, unspecified
0.000 0.994 0.006
Z52.9 Donor of unspecified organ or tissue
0.000 0.994 0.006
Z52.8 Donor of other organs and tissues
0.000 0.994 0.006
Z52.7 Heart donor
0.000 0.994 0.006
Z52.6 Liver donor
0.000 0.994 0.006
Z52.5 Cornea donor
0.000 0.994 0.006
Z52.2 Bone donor
0.000 0.994 0.006
Z52.1 Skin donor
0.000 0.994 0.006
Z52.0 Blood donor
0.000 0.994 0.006
Z41.9 Procedures for purposes other than remedying health state, unspecified
0.000 0.994 0.006
Z41.3 Ear piercing
0.000 0.994 0.006
Z41.2 Routine and ritual circumcision
0.000 0.994 0.006
Z41.0 Hair transplant
0.000 0.994 0.006
S06.21 Diffuse brain injury (with open intracranial wound)
0.000 0.994 0.006
Z42.3 Follow-up care involving plastic surgery of upper extremity
0.000 0.994 0.006
S06.80 Other intracranial injuries (without open intracranial wound)
0.000 0.994 0.006
S06.40 Epidural haemorrhage (without open intracranial wound)
0.000 0.994 0.006
Z52.3 Bone marrow donor
0.000 0.994 0.006
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.006 0.994 0.000
G81 Hemiplegia
0.000 0.994 0.006
I95-I99 Other and unspecified disorders of the circulatory system
0.000 0.994 0.006
Z46.3 Fitting and adjustment of dental prosthetic device
0.000 0.994 0.006
S06.61 Traumatic subarachnoid haemorrhage (with open intracranial wound)
0.000 0.994 0.005
Z40 Prophylactic surgery
0.000 0.994 0.005
Z42.4 Follow-up care involving plastic surgery of lower extremity
0.000 0.994 0.005
T46 Poisoning by agents primarily affecting the cardiovascular system
0.006 0.994 0.000
Z46.8 Fitting and adjustment of other specified devices
0.000 0.994 0.005
T36-T50 Poisoning by drugs, medicaments and biological substances
0.006 0.994 0.000
Z43.1 Attention to gastrostomy
0.000 0.995 0.005
Z44.3 Fitting and adjustment of external breast prosthesis
0.000 0.995 0.005
S06.0 Concussion
0.000 0.995 0.005
T43.3 Phenothiazine antipsychotics and neuroleptics
0.005 0.995 0.000
Z46.5 Fitting and adjustment of ileostomy and other intestinal appliances
0.000 0.995 0.005
Z41.8 Other procedures for purposes other than remedying health state
0.000 0.995 0.005
Z49.0 Preparatory care for dialysis
0.000 0.995 0.005
I99 Other and unspecified disorders of circulatory system
0.000 0.995 0.005
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.005 0.995 0.000
Z08 Follow-up examination after treatment for malignant neoplasm
0.005 0.995 0.000
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm
0.005 0.995 0.000
S06.30 Focal brain injury (without open intracranial wound)
0.000 0.995 0.005
Z42.9 Follow-up care involving plastic surgery, unspecified
0.000 0.995 0.005
Z42.8 Follow-up care involving plastic surgery of other body part
0.000 0.995 0.005
S06.81 Other intracranial injuries (with open intracranial wound)
0.000 0.995 0.005
S06.41 Epidural haemorrhage (with open intracranial wound)
0.000 0.995 0.005
T45.1 Antineoplastic and immunosuppressive drugs
0.005 0.995 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.005 0.995 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.005 0.995 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.005 0.995 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.005 0.995 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.005 0.995 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.005 0.995 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.005 0.995 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.005 0.995 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.005 0.995 0.000
T44.0 Anticholinesterase agents
0.005 0.995 0.000
Z46.9 Fitting and adjustment of other unspecified device
0.000 0.995 0.005
Z46.4 Fitting and adjustment of orthodontic device
0.000 0.995 0.005
Z46.1 Fitting and adjustment of hearing aid
0.000 0.995 0.005
Z46.0 Fitting and adjustment of spectacles and contact lenses
0.000 0.995 0.005
Z92.3 Personal history of irradiation
0.000 0.995 0.005
S06.31 Focal brain injury (with open intracranial wound)
0.000 0.995 0.005
Z41.1 Other plastic surgery for unacceptable cosmetic appearance
0.000 0.995 0.005
N28 Other disorders of kidney and ureter, not elsewhere classified
0.005 0.995 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.005 0.995 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.005 0.995 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.005 0.995 0.000
Z00.0 General medical examination
0.005 0.995 0.000
M20.1 Hallux valgus (acquired)
0.005 0.995 0.000
T43.6 Psychostimulants with abuse potential
0.005 0.995 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.005 0.995 0.000
S06.11 Traumatic cerebral oedema (with open intracranial wound)
0.000 0.995 0.004
S06.10 Traumatic cerebral oedema (without open intracranial wound)
0.000 0.995 0.004
S06.71 Intracranial injury with prolonged coma (with open intracranial wound)
0.000 0.995 0.004
S06.70 Intracranial injury with prolonged coma (without open intracranial wound)
0.000 0.995 0.004
Z52.4 Kidney donor
0.000 0.995 0.004
T43.0 Tricyclic and tetracyclic antidepressants
0.005 0.995 0.000
Z42.2 Follow-up care involving plastic surgery of other parts of trunk
0.000 0.995 0.004
S06.91 Intracranial injury, unspecified (with open intracranial wound)
0.000 0.995 0.004
S06.90 Intracranial injury, unspecified (without open intracranial wound)
0.000 0.995 0.004
T45.2 Vitamins, not elsewhere classified
0.004 0.995 0.000
T36 Poisoning by systemic antibiotics
0.004 0.995 0.000
M20.6 Acquired deformity of toe(s), unspecified
0.004 0.996 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.004 0.996 0.000
S02.20 Fracture of nasal bones (closed)
0.000 0.996 0.004
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm
0.004 0.996 0.000
Z42.0 Follow-up care involving plastic surgery of head and neck
0.000 0.996 0.004
G81.0 Flaccid hemiplegia
0.000 0.996 0.004
T43.9 Psychotropic drug, unspecified
0.004 0.996 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.004 0.996 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.004 0.996 0.000
Z08.1 Follow-up examination after radiotherapy for malignant neoplasm
0.004 0.996 0.000
T45.0 Antiallergic and antiemetic drugs
0.004 0.996 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.